Saturday, November 2, 2024
HomeTagsImmunotherapy Regimen

Immunotherapy Regimen

IMFINZI Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen

AstraZeneca’s IMFINZI (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics